Linkedin
SCIRENT: Advancing cardiovascular research for a healthier tomorrow
Get in touch
BLOG 

Cardiovascular Clinical Research

Discover the latest updates on cardiovascular clinical research, innovative studies, and exciting conference news. Join us on our journey as we explore the latest discoveries and innovations transforming how we understand and treat cardiovascular diseases.

Insights

Precision Medicine in Cardiovascular Disease

Author: Wilhelm Haverkamp Published on:
We are at an unusual moment in cardiovascular medicine. For the first time, the biological mechanisms underlying inherited cardiomyopathies and arrhythmia syndromes are not merely characterised but therapeutically addressable. Artificial intelligence is unlocking diagnostic information embedded in data that clinicians...
Insights

Germany Fast-Track Pathway for Early Clinical Development

Author: Rita Hertrampf Published on:
Germany has significantly improved the attractiveness of early clinical development through the Medical Research Act (Medizinforschungsgesetz, MFG) to expedite the approval of mononational clinical trials. Sponsors conducting innovative studies in Germany can benefit from accelerated regulatory processes, streamlined ethics review,...
Press release

Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT

Author: Wiebke Lesch Published on:
Berlin, 16. April 2026. SCIRENT announced the appointment of Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer (CMO), effective immediately. In this role, Prof. Haverkamp will further strengthen SCIRENT’s medical and scientific leadership and expand the company’s activities in drug...
Conferences

SCIRENT to Participate in CSI Focus D-HF 2025 in Frankfurt

Author: Wiebke Lesch Published on:
SCIRENT, a full-service cardiovascular Contract Research Organization (CRO) specializing in clinical studies for heart failure and cardiac devices, will participate in the upcoming CSI Focus D-HF 2025, taking place December 5–6, 2025, in Frankfurt, Germany. The conference is the leading...
Conferences

SOURCE-HF Phase 2 Study – collaboration announcement between Relaxera and Scirent

Author: Angelika Gaufer Published on:
A behind-the-scenes look at ESC 2025 in Madrid At this year’s European Society of Cardiology (ESC) Congress in Madrid, the spotlight was not only on cutting-edge research and innovation in cardiovascular medicine. One of the highlights at the SCIRENT booth was a video...
Conferences

ESC Heart Failure 2025 – A Very Special Congress for SCIRENT in Belgrade

Author: Angelika Gaufer Published on:
The ESC Heart Failure Congress in Belgrade this year was a truly special event for all of us at SCIRENT. Not only because it is one of the most important international gatherings in our field, but also because it was...
Conferences

SCIRENT is heading to ACC.25 in Chicago!

Author: Wiebke Lesch Published on:
We’re excited to announce that SCIRENT, a leading Contract Research Organization (CRO) specializing in cardiovascular research, will be attending the American College of Cardiology's Annual Scientific SessionACC.25, taking place from March 29–31, 2025 at McCormick Place, Chicago, IL. With over 300 sessions, groundbreaking research presentations, and unparalleled networking...
Careers

From Big Pharma to specialized CRO – A Conversation on International Women’s Day

Author: Goran Ebersold Published on:
It's early March, and as spring begins, we celebrate a special day that is even a public holiday in Berlin: International Women's Day. This day not only reminds us of women's achievements and rights but also of how important their...
Insights

Success Through Punctuality: How Adhering to Timelines Secures Funding for Clinical Trials

Author: Goran Ebersold Published on:
In clinical research, milestones like study initiation, patient recruitment, or the completion of data analysis are closely tied to investor payments. Funding for the next phase is only released once a milestone is achieved. This structure provides clarity but also...
Conferences

SCIRENT at THT 2025 in Boston: Commitment and Expertise in Cardiovascular Research

Author: Wiebke Lesch Published on:
As a leading Contract Research Organization specializing in cardiovascular research, SCIRENT is eager to join the THT Conference in Boston from February 11-13, 2025. This conference is a crucial hub for professionals to exchange information about advanced therapies and technologies. We take pride...
Insights

Milestones Achieved: PEI Approval and First Participant Dosed in TGD001 Phase 1 Study

Author: Goran Ebersold Published on:
At SCIRENT, we are excited to work for TargED Biopharmaceuticals B.V. in developing TGD001, an innovative thrombolytic therapy for thrombotic diseases.  PEI Approval in Record Time In October 2024, TargED Biopharmaceuticals B.V. received approval from the Paul-Ehrlich-Institut (PEI) for a...
Conferences

SCIRENT at ESC Congress 2024: Pioneering Cardiovascular Research

Author: Goran Ebersold Published on:
Date: Friday, August 30 - Monday, September 2, 2024 Location: London, United Kingdom We are thrilled to announce that SCIRENT, a leading European cardiovascular clinical research organization, will be participating in this year's ESC Congress 2024 in London. Visit us...
Insights

Celebrating Success: Imbria Pharmaceuticals’ Phase 2 IMPROVE-HCM Trial Results

Author: Goran Ebersold Published on:
We are thrilled to convey our heartfelt congratulations to Imbria Pharmaceuticals on the outstanding results from the Phase 2 IMPROVE-HCM clinical trial. The trial, which evaluated ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM), has shown significant improvements in...
Insights

Echo Core Lab is a Key for Using Echocardiography in Clinical Trials

Author: Aravindkumar Radhakrishnan Published on:
Echocardiography is a noninvasive method to assess cardiac anatomy, function, and hemodynamics and may provide important data on the effects of a new drug or medical device. In many cardiovascular clinical trials, echocardiography data are used for assessing eligibility and...
Insights

Navigating Change: Navigating a CRO Transition in Cardiovascular Research

Author: Goran Ebersold Published on:
The ability to steer through changes and skillfully manage a transition to another Contract Research Organization (CRO) is sometimes essential for progress in the dynamic field of cardiovascular research. CROs are indispensable; they accelerate the translation of innovative cardiovascular therapies...
Insights

Integrating Phase 1 Studies in Healthy Volunteers and Patients with Cardiovascular Disease – A Comprehensive Approach  

Author: Maximilian Posch Published on:
Phase 1 clinical studies are the initial step in drug development, designed to assess the safety and tolerability of a new molecule in humans. Traditionally investigational medicinal products (IMP) were tested in multiple Phase 1 clinical trials that enrolled large...
Insights

Site Management and Study Start-Up Enhancement: A Strategic Focus in Cardiovascular Research

Author: Goran Ebersold Published on:
Insights into best practices and efficiency improvement in clinical trials highlight the importance of thorough site identification and selection in the field of cardiovascular research. Managing the complex regulatory environment requires well-thought-out document management and early engagement with regulatory authorities....
Insights

Maximizing Success in Cardiovascular Trials: The Advantage of Partnering with a Specialist CRO

Author: Maximilian Posch Published on:
The industry spent over $200 billion globally in 2021 on developing new therapies for treating cardiovascular diseases. However, it’s estimated that more than half of the investment in clinical development is wasted. Various factors contribute to this, including a lack...
Careers

What is a Clinical Research Associate doing?

Author: Goran Ebersold Published on:
Maike, 32, and Nadja, 32, work as Clinical Research Associates (CRA) in medical research. They discuss what makes this job unique and why they enjoy working as CRAs. Maike, how did your day start today? Maike: I returned from Oslo...
Conferences

SCIRENT is excited to participate at the TCT Conference 2023 in San Francisco

Author: Wiebke Lesch Published on:
SCIRENT is excited to participate at the TCT Conference from October 23-26, 2023, in San Francisco. The Transcatheter Cardiovascular Therapeutics (TCT) conference, hosted by the Cardiovascular Research Foundation (CRF), is the world's premier educational forum for interventional cardiovascular medicine. For...
Load More

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Book a meeting

Thank you for your application.

We will get in touch shortly.